Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)
Clinical trial NCT02878798 · COMPLETED
Trial details
- NCT number
- NCT02878798
- Sponsor
- Virginia Commonwealth University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2021-09-28
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.